Product
hCT-MSC
1 clinical trial
2 indications
Indication
Autism Spectrum DisorderIndication
AutismClinical trial
A PHASE I STUDY OF hCT-MSC, AN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL PRODUCT, IN ADULTS WITH AUTISM SPECTRUM DISORDERStatus: Active (not recruiting), Estimated PCD: 2024-06-01